Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
99mTc-ADAPT6 SPECT Imaging of HER2 Expression in Breast Cancer
NCT05412446Phase 2Completed
- Sponsor
- Tomsk National Research Medical Centre of the Russian Academy of Sciences
- Start
- May 2022
- Primary completion
- Dec 2022
- Modality
- Carrier/Scaffold Proteins
- Countries
- 1
01
Overview
A Phase 2 trial of [99mTc]Tc-ADAPT6 in breast cancer, sponsored by Tomsk National Research Medical Centre of the Russian Academy of Sciences. Started May 2022; status: completed.
02
Drugs
[99mTc]Tc-ADAPT6
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT05412446.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05412446.